Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I am very pleased to welcome Susan to the Board of Scancell. Susan's considerable experience in investment banking will be invaluable for any potential future licensing and corporate transactions."
Aim Holdings ........
""invaluable for any potential future licensing and corporate transactions."
Flash Names ....... Big Market Caps ..... makes absolutely no difference
if you want to join Ponzi schemes ........ plenty out there
If you want to back Solid Science ....... and make serious wedge .. "all about the number you hold" not the number you don't
1999 ......... this Paper is what sparked that long road of development and understanding ...... and its "understanding" why things may fail that Lindy concentrated on ..
https://onlinelibrary.wiley.com/doi/full/10.1002/%28SICI%291097-0215%2820000101%2985%3A1%3C87%3A%3AAID-IJC16%3E3.0.CO%3B2-K
So when you have an Immune Response which is detectable ... it often does not translate into Efficacy ......
https://www.fiercebiotech.com/biotech/roche-biontech-post-low-response-rate-cancer-vaccine-trial
Abstract
Therapeutic cancer vaccines often do not substantially reduce tumour burden, despite stimulating anti-tumour cytotoxic T lymphocytes (CTLs). Recent experiments have shown that the majority of vaccine-elicited CTLs may be of low-avidity. Moreover, low-avidity CTLs, which are abundant, do not kill cancer cells and potentially inhibit the ability of high-avidity T cells to kill cancer cells. By modelling CTL selection using a system of ordinary differential equations, we show that the efficacy of the peptide vaccine may be improved by controlling its delivery and dosage to preferentially elicit high-avidity CTLs. Our simulations predict that weekly, reduced doses of a vaccine may result in a greater than 90% reduction in cancer concentration. By contrast, a standard vaccine protocol such as a high-dose injection given every 2 weeks induces only a 65% reduction. Our model demonstrates a proof-of-concept approach to targeting immune responses for CTL selection, thereby offering a technique to potentially improve existing therapies.
https://pubmed.ncbi.nlm.nih.gov/31704311/
this Game is all about Binding .............
"AVId"mab
High Avidity
Potent immunogens .... Moditope
so if you want to kill Cancer Cells you have to generate the Optimal vaccine ........... near enough is just not good enough
and that Optimal Cancer vaccine solves the problem in vaccinated the Aged Population for Virals
Covidity ....
suggest you guys watch the Video again .... either the CEO is agreeing with me or I am agreeing with Him .........
£8 ........ https://youtu.be/Q9jscF9MNpQ
as big as the size of BioNtech what they worth now $15 billion ?
Scancells pipeline is huge .... and because its platform based you only need efficacy in the lead products to give the Green light on the Rest ..
Why do you think Covidity got funded ......... ? that funding round allowed the Gov to consider rather than rush
as reliable as a Tick Tock ...... Scancells Science
Tick Tock
when the result comes out look at the "lowering" of PSA levels and is it sustained
then compare that to current standard of care ........
that's the efficacy .. i suspect no shrinkage in the tumor
I suspect he last two patients data might indicate something .........
however you need to compare that trial numbers compared to trials of the standard of care ... that will be miles apart thus making the data very difficult to interpret but very easy to "jazz up".....
so the comparison is this treatment
https://www.pcf.org/about-prostate-cancer/prostate-cancer-treatment/hormone-therapy-prostate-cancer/
yes ... the vIrus infects individuals different ............. the vaccine has to deal with that and more importantly Age and other immune related deficits
so ... multiple targets coupled with High Avidity T cells .......... gives Scancell the edge
but the market has not woken up to that yet .. and what it could be worth as a secondary vaccine strategy long term even if you have been given the early bird vaccine , especially if its efficacy is only targeting 50% of the population ... what happens to the other 50% ? well you need Covidity ....
That's just it .. we don't know, why somebody with moderate symptoms can have this for 3 months .. than another with evidence of lung scaring gets rushed into hospital and passes away .. the scarring is the result of damage from Covid that has healed or Cytokine damage ... perhaps .. but with Covid its seem's a very personal relationship between Virus and Host .. which is quite a challenge for the vaccine
well we had sorted it ............ after the last "interpreted" posts previously, i called them "this is fake news" so the other day i apologised which he accepted ... Good Grace on my side ... read the very recent history ....
which is why i am so miffed now ........ why repeat the same "play" .... what was the advantage ? absolutely NONE
hence i posted it as Game Playing ...
in fairness every one is commenting ... But not one post has agreed that Bermuda was correct .....
to translate my post into ""what he interpreted""
so who actually will stand behind Bermuda in that respect and why ?
rather than looking at what i posted about Fake as Tactless ...